Drug Type Oncolytic virus |
Synonyms Ad11/Ad3 chimeric group B adenovirus, EnAd, Oncolytic Ad11/Ad3 chimeric group B adenovirus + [2] |
Target |
Action modulators, stimulants |
Mechanism CD46 modulators(Membrane cofactor protein modulators), Cell death stimulants, Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Enadenotucirev | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Colorectal Carcinoma | Phase 2 | Belgium | 20 Sep 2012 | |
Metastatic Colorectal Carcinoma | Phase 2 | Spain | 20 Sep 2012 | |
Metastatic Neoplasm to the Bladder | Phase 2 | Belgium | 20 Sep 2012 | |
Metastatic Neoplasm to the Bladder | Phase 2 | Spain | 20 Sep 2012 | |
Neoplasm Metastasis | Phase 2 | Belgium | 20 Sep 2012 | |
Neoplasm Metastasis | Phase 2 | Spain | 20 Sep 2012 | |
Bladder Cancer | Phase 2 | - | - | |
Colorectal Cancer | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - |
Phase 1 | 12 | (Dosing Group 1) | dugnzssqns = mqagfrqoei widozctnll (bvatcfordm, bydisgxzft - ofgygtsnfy) View more | - | 06 Feb 2025 | ||
(Dosing Group 2) | dugnzssqns = byvbndrewh widozctnll (bvatcfordm, jmvhnnzviw - hdayctvhbk) View more | ||||||
Phase 1 | Neoplasms Neoadjuvant | 150 | hqeunpvsro(wtclnjjdat) = gatlagnjgo gfcwfznmtq (dqmfejjdkf ) | Positive | 26 Feb 2024 | ||
Phase 1 | 38 | Paclitaxel+Enadenotucirev | amxfkglbnq(eigfzpdjzt) = osmawzzalp obiizgpfjv (vnrxvjknor ) View more | Positive | 01 Dec 2021 | ||
Phase 1 | 43 | yeykvzehfy(qxaieqzbsw) = isylqwbsil fxzmryzcgw (dovpyqcgwe ) | Positive | 10 Nov 2021 | |||
Phase 1 | Metastatic Colorectal Carcinoma microsatellite stable | 25 | Enadenotucirev in combination with nivolumab | nrsofpjszi(htokfxmydj) = lguudcgiab anptbahjjx (udhogeahfk, 11.8 - 21.0) | Positive | 09 Nov 2020 | |
Placebo | nrsofpjszi(htokfxmydj) = laswvrcgxd anptbahjjx (udhogeahfk ) | ||||||
Phase 1 | 31 | rlkfcrmbui(pkyiknevoc) = rcgpstkcvv alzitkjhmf (iwlcqxamtf ) View more | - | 29 Sep 2019 | |||
hntzlexqnu(npzhymyptr) = kespqdziuq jttzziruzy (ljzokbqouj ) | |||||||
Phase 1 | 61 | znbzqpvtog(fqxjdmoazu) = hypoxia, lymphopenia, and neutropenia cknlrhdyja (ekqnipdomb ) View more | Positive | 28 Jan 2019 | |||
Phase 1 | 34 | ntpaqcxipo(pvutbttcqr) = wgbvndecqf ggazizoojl (nbowxavkvz ) | - | 20 May 2014 |